Clinical Trials in Myelofibrosis: Endpoints

from Medical News Podcast · host PeerDirect Publishing

Drs. Komrokji and Kuykendall review the evolution of clinical trial endpoints in myelofibrosis studies. They discuss traditional measures of disease control, such as spleen volume reduction and hematologic response, as well as expanded endpoints that reflect the biological and symptomatic aspects of myelofibrosis.

Episode metadata supplied by the publisher feed · Published Jan 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Clinical Trials in Myelofibrosis: Endpoints

0:00 13:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical News Podcast?

This episode is 13 minutes long.

When was this Medical News Podcast episode published?

This episode was published on January 9, 2025.

Can I download this Medical News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!